Comparison of Deep Neck Flexor Strengthening and Motor Learning-Based Neuroplasticity Training for Forward Head Posture

NCT07337824 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-01-13

No results posted yet for this study

Summary

The aim of this randomized clinical trial is to compare the effects of deep neck flexor strengthening and motor learning-based neuroplasticity training on craniovertebral angle, deep neck flexor strength, proprioception, and symptom recurrence in individuals with forward head posture (FHP).

The study will be conducted at Riphah International University, Gulberg Green Campus. A total of 74 participants with forward head posture will be recruited using non-probability convenience sampling and randomly allocated into two groups (37 participants per group). Group A will receive deep neck flexor strengthening exercises, while Group B will receive motor learning-based neuroplasticity training. Both groups will undergo three sessions per week for four weeks. Assessments will be performed at baseline, post-intervention, and at one-month follow-up to assess symptom recurrence. Data will be analyzed using SPSS version 27.

Conditions

  • Forward Head Posture

Interventions

OTHER

Deep neck flexor strengthening

Chin tuck exercises, Isometric cervical flexion using gentle resistance, Prone head lift exercises. Frequency: 3 sessions per week, Duration: 4 weeks (12 sessions total).

OTHER

Motor learning based neuroplasticity training

Task-specific postural training using visual (laser), auditory (metronome), and proprioceptive feedback. Progressive balance and coordination exercises under varying environmental conditions. Static and dynamic postural control tasks with intertrial variability. Frequency: 3 sessions per week, Duration: 4 weeks (12 sessions total)

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Aisha Razzaq, PHD* · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-02
Primary Completion
2026-12-30
Completion
2027-01-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07337824 on ClinicalTrials.gov